Vincent Polivka
@Vanguard Capital Wealth Advisors
Latest period2024 - Q3ReportedManaged Assets$95.093MTotal holdings116
Assets growth rate-35.69%Assets growth rate (2-Q avg)-15.83%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Vanguard Capital Wealth Advisors's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 116 positions.
Assets under management
The assets under management (AUM) of Vanguard Capital Wealth Advisors over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 95.093M in assets, with a quarterly growth rate of -35.69% and a 2-quarter average growth rate of -15.83%. The portfolio is managed by Vincent Polivka, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
VZVerizon Communications Inc
| 0.42% | $397,692 8,855 shares@ $44.92 avg price | Decreased -34.51% |
ONONOn Hldg Ag
| 0.39% | $368,502 7,348 shares@ $50.15 avg price | Decreased -60.7% |
CVXChevron Corp New
| 0.37% | $347,263 2,358 shares@ $147.28 avg price | Decreased -32.8% |
BMYBristol-myers Squibb Co
| 0.36% | $341,484 6,600 shares@ $51.74 avg price | Decreased -12% |
PFEPfizer Inc
| 0.34% | $318,340 11,000 shares@ $28.94 avg price | Decreased -15.6% |
DISDisney Walt Co
| 0.33% | $312,200 3,246 shares@ $96.18 avg price | Decreased -7.12% |
MPCMarathon Pete Corp
| 0.33% | $310,044 1,903 shares@ $162.93 avg price | Decreased -53.55% |
VRTXVertex Pharmaceuticals Inc
| 0.33% | $304,627 655 shares@ $465.08 avg price | Decreased -22.02% |
COSTCostco Whsl Corp New
| 0.32% | $301,755 340 shares@ $887.52 avg price | Decreased -70.38% |
FCXFreeport-mcmoran Inc
| 0.32% | $301,317 6,036 shares@ $49.92 avg price | Decreased -32.25% |